Other specified and unspecified endocrine disorders

Code Families in This Category

• E34 Other endocrine disorders · 20
• E16 Other disorders of pancreatic internal secretion · 10
• E20 Hypoparathyroidism · 10
• E27 Other disorders of adrenal gland · 9
• E28 Ovarian dysfunction · 8
• E31 Polyglandular dysfunction · 8
• E26 Hyperaldosteronism · 7
• E21 Hyperparathyroidism and other disorders of parathyroid gland · 6
• E24 Cushing's syndrome · 6
• E29 Testicular dysfunction · 4
• E30 Disorders of puberty, not elsewhere classified · 4
• E32 Diseases of thymus · 4
• E25 Adrenogenital disorders · 3
• A18 Tuberculosis of other organs · 2
• A39 Meningococcal infection · 1
• E15 Nondiabetic hypoglycemic coma · 1
• E35 Disorders of endocrine glands in diseases classified elsewhere · 1

ICD-10-CM Codes in This Category (first 100 of 104)

• A18.7 — Tuberculosis of adrenal glands
• A18.82 — Tuberculosis of other endocrine glands
• A39.1 — Waterhouse-Friderichsen syndrome
• E15 — Nondiabetic hypoglycemic coma
• E16.0 — Drug-induced hypoglycemia without coma
• E16.1 — Other hypoglycemia
• E16.2 — Hypoglycemia, unspecified
• E16.3 — Increased secretion of glucagon
• E16.4 — Increased secretion of gastrin
• E16.8 — Other specified disorders of pancreatic internal secretion
• E16.9 — Disorder of pancreatic internal secretion, unspecified
• E16.A1 — Hypoglycemia level 1
• E16.A2 — Hypoglycemia level 2
• E16.A3 — Hypoglycemia level 3
• E20.0 — Idiopathic hypoparathyroidism
• E20.1 — Pseudohypoparathyroidism
• E20.8 — Other hypoparathyroidism
• E20.810 — Autosomal dominant hypocalcemia
• E20.811 — Secondary hypoparathyroidism in diseases classified elsewhere
• E20.812 — Autoimmune hypoparathyroidism
• E20.818 — Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
• E20.819 — Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
• E20.89 — Other specified hypoparathyroidism
• E20.9 — Hypoparathyroidism, unspecified
• E21.0 — Primary hyperparathyroidism
• E21.1 — Secondary hyperparathyroidism, not elsewhere classified
• E21.2 — Other hyperparathyroidism
• E21.3 — Hyperparathyroidism, unspecified
• E21.4 — Other specified disorders of parathyroid gland
• E21.5 — Disorder of parathyroid gland, unspecified
• E24.1 — Nelson's syndrome
• E24.2 — Drug-induced Cushing's syndrome
• E24.3 — Ectopic ACTH syndrome
• E24.4 — Alcohol-induced pseudo-Cushing's syndrome
• E24.8 — Other Cushing's syndrome
• E24.9 — Cushing's syndrome, unspecified
• E25.0 — Congenital adrenogenital disorders associated with enzyme deficiency
• E25.8 — Other adrenogenital disorders
• E25.9 — Adrenogenital disorder, unspecified
• E26.01 — Conn's syndrome
• E26.02 — Glucocorticoid-remediable aldosteronism
• E26.09 — Other primary hyperaldosteronism
• E26.1 — Secondary hyperaldosteronism
• E26.81 — Bartter's syndrome
• E26.89 — Other hyperaldosteronism
• E26.9 — Hyperaldosteronism, unspecified
• E27.0 — Other adrenocortical overactivity
• E27.1 — Primary adrenocortical insufficiency
• E27.2 — Addisonian crisis
• E27.3 — Drug-induced adrenocortical insufficiency
• E27.40 — Unspecified adrenocortical insufficiency
• E27.49 — Other adrenocortical insufficiency
• E27.5 — Adrenomedullary hyperfunction
• E27.8 — Other specified disorders of adrenal gland
• E27.9 — Disorder of adrenal gland, unspecified
• E28.0 — Estrogen excess
• E28.1 — Androgen excess
• E28.2 — Polycystic ovarian syndrome
• E28.310 — Symptomatic premature menopause
• E28.319 — Asymptomatic premature menopause
• E28.39 — Other primary ovarian failure
• E28.8 — Other ovarian dysfunction
• E28.9 — Ovarian dysfunction, unspecified
• E29.0 — Testicular hyperfunction
• E29.1 — Testicular hypofunction
• E29.8 — Other testicular dysfunction
• E29.9 — Testicular dysfunction, unspecified
• E30.0 — Delayed puberty
• E30.1 — Precocious puberty
• E30.8 — Other disorders of puberty
• E30.9 — Disorder of puberty, unspecified
• E31.0 — Autoimmune polyglandular failure
• E31.1 — Polyglandular hyperfunction
• E31.20 — Multiple endocrine neoplasia [MEN] syndrome, unspecified
• E31.21 — Multiple endocrine neoplasia [MEN] type I
• E31.22 — Multiple endocrine neoplasia [MEN] type IIA
• E31.23 — Multiple endocrine neoplasia [MEN] type IIB
• E31.8 — Other polyglandular dysfunction
• E31.9 — Polyglandular dysfunction, unspecified
• E32.0 — Persistent hyperplasia of thymus
• E32.1 — Abscess of thymus
• E32.8 — Other diseases of thymus
• E32.9 — Disease of thymus, unspecified
• E34.0 — Carcinoid syndrome
• E34.00 — Carcinoid syndrome, unspecified
• E34.01 — Carcinoid heart syndrome
• E34.09 — Other carcinoid syndrome
• E34.1 — Other hypersecretion of intestinal hormones
• E34.2 — Ectopic hormone secretion, not elsewhere classified
• E34.3 — Short stature due to endocrine disorder
• E34.30 — Short stature due to endocrine disorder, unspecified
• E34.31 — Constitutional short stature
• E34.321 — Primary insulin-like growth factor-1 (IGF-1) deficiency
• E34.322 — Insulin-like growth factor-1 (IGF-1) resistance
• E34.328 — Other genetic causes of short stature
• E34.329 — Unspecified genetic causes of short stature
• E34.39 — Other short stature due to endocrine disorder
• E34.4 — Constitutional tall stature
• E34.50 — Androgen insensitivity syndrome, unspecified
• E34.51 — Complete androgen insensitivity syndrome

The remaining 4 codes are reachable through the code families above.